Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dana Paquin
An Analysis of Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia With Imatinib-Resistant Mutations
Mathematical Biosciences
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Simulation
Immunology
Biological Sciences
Medicine
Agricultural
Modeling
Related publications
Characteristics of Dasatinib- And Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Clinical Cancer Research
Cancer Research
Oncology
Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia
Clinical Journal of Oncology Nursing
Oncology
Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Increased Cortical Bone Mineralization in Imatinib Treated Patients With Chronic Myelogenous Leukemia
Haematologica
Hematology
Treatment of Resistant Chronic Myelogenous Leukemia With Ponatinib: One Centre Experience
Hematology & blood transfusion: interdepartamental collection
Characteristics of the TCR Vβ Repertoire in Imatinib-Resistant Chronic Myeloid Leukemia Patients With ABL Mutations
Science China Life Sciences
Genetics
Molecular Biology
Environmental Science
Biochemistry
Biological Sciences
Agricultural
Treatment Options for Patients With Chronic Myeloid Leukemia Who Are Resistant to or Unable to Tolerate Imatinib
Clinical Therapeutics
Pharmacology
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia
Haematologica
Hematology